“Tecentriq, in combination with Avastin, is the only cancer immunotherapy treatment, approved by NICE for this indication,” said Gemma Boni, head of liver cancer at Roche Products Ltd. “We ...

Sanofi has taken a small step towards potentially ... The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement ...

There’s a new Muse in town. Sanofi, Formation Bio and OpenAI have joined forces to build an AI-powered tool designed to improve drug development by speeding up clinical trial recruitment.

Sanofi (Symbol: SNY) presently has an above average rank, in the top 50% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further research by investors.

New Delhi: Reviewing the Phase III clinical trial protocol of the GZ402671 (Venglustat) presented by the pharma major Sanofi, the Subject Expert Committee ... She also has spread out exposure to ...

It has its own manufacturing facility at Goa. It sells products through independent distributors primarily in India.Sanofi India's products viz. Lantus Combiflam Amaryl and Allegra feature in the top ...

Sanofi (Euronext: SAN) has announced that the UK's health technology ... Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information ...

Are you a print subscriber? Activate your account. 25 min 43 sec ago By Rod Sobral - 3 hours 7 min ago By Tim Nudd - 3 hours 7 min ago By Erika Wheless - 3 hours 37 min ago By Garett Sloane - 3 ...